Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease

Pi Chun Cheng1,2, Deborah R Liptzin3, Katiana Garagozlo4

  • 1Division of Pediatric Pulmonology, Allergy, and Sleep Medicine, Riley Hospital for Children, Indianapolis, Indiana, USA.

Pediatric Pulmonology
|April 17, 2025
PubMed

Insights

Pediatric rare lung diseases like chILD and bronchiectasis are better understood with new 2024 research. Advances improve diagnosis and treatment for children with these rare conditions.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Diffuse Lung Diseases

Background:

  • Pediatric rare and diffuse lung diseases present complex diagnostic and therapeutic challenges.
  • Conditions include children's interstitial and diffuse lung disease (chILD), non-cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer.

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of pediatric rare and diffuse lung diseases.
  • To contextualize new findings within current clinical practices for pediatric patients.

Main Methods:

  • Literature review of recent publications (2024) in pediatric pulmonology and related journals.
  • Synthesis of new insights into pathophysiology, disease progression, diagnostic tools, and therapeutic approaches.

Main Results:

  • New understanding of pathophysiology and disease progression in chILD, non-CF bronchiectasis, and childhood cancer-related lung issues.
  • Emerging diagnostic tools and innovative therapeutic strategies have been identified.
  • Recent research offers improved approaches to managing these rare pediatric lung conditions.

Conclusions:

  • The field is rapidly advancing, offering improved diagnostic and therapeutic options for children.
  • Ongoing research is crucial for enhancing clinical care and patient outcomes in pediatric rare lung diseases.

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
783
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
105
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
138
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
174
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K